By Sommer Brokaw
\nUPI<\/p>\n
Aug. 17 (UPI) —<\/span>\u00a0Israel and United Arab Emirates stem cell therapy companies signed an agreement Monday to collaborate on researching potential treatment for\u00a0COVID-19<\/a>.<\/p>\n The accord between Israel’s Pluristem Therapeutics and UAE’s\u00a0Abu Dhabi<\/a>\u00a0Stem Cells Center\u00a0aims to capitalize on each company’s expertise to develop therapies and regenerative medicines for the treatment of severe diseases including COVID-19,\u00a0according to a joint statement<\/a>.<\/p>\n Both companies have been treating COVID-19 patients with stem cells.<\/p>\n Pluristem has been treating COVID-19 patients with a placenta-based stem cell therapy. The U.S.\u00a0Food and Drug Administration<\/a>\u00a0cleared the<\/a>\u00a0Israel stem cell therapy company in May for a\u00a0Phase II<\/a>\u00a0study of the treatment for severe COVID-19 cases. Preliminary\u00a0results released in May<\/a>\u00a0from compassionate-use programs in Israel and the United States were promising, showing that 75 percent of participants no longer needed mechanical ventilation within 28 days.<\/p>\n The Abu Dhabi Stem Cells Center has started a therapy that returns blood-based stem cells back into the patient’s lungs as a fine mist through a nebulizer.<\/p>\n “We are extremely proud to partner with our colleagues at the ADSCC by sharing knowledge and expertise that we believe will advance healthcare within and across our borders,” Pluristem CEO and President Yaky Yanay said in the statement.<\/p>\n The ADSCC’s General Manager Dr. Yendry Ventura also commented on the deal in the statement.<\/p>\n “Pluristem is a major player in the cell therapy field with years of experience, a unique platform and robust clinical pipeline,” Ventura said. “We are excited to join forces and to promote the research and development of cell therapies for the best of the patients and the human society as a whole.”<\/p>\n The deal\u00a0is the second<\/a>\u00a0cross-border agreement since President\u00a0Donald Trump<\/a>\u00a0brokered a deal to normalize<\/a>\u00a0ties between Israel and the UAE. It\u00a0follows a cross-border deal<\/a>\u00a0on Sunday between UAE-based APEX National Investment and Israel’s TeraGroup to conduct research on the coronavirus.<\/p>\n ___ Israel and UAE team up on stem cell therapy research for COVID-19 By Sommer Brokaw UPI Aug. 17 (UPI) —\u00a0Israel and United Arab Emirates stem cell therapy companies signed an agreement Monday to collaborate on researching potential treatment for\u00a0COVID-19. The … Continue reading
\nhttps:\/\/www.upi.com\/Top_News\/World-News\/2020\/08\/17\/Israel-and-UAE-team-up-on-stem-cell-therapy-research-for-COVID-19\/9261597685798\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"